NEWS | RESEARCH
Bone Graft Manufacturer Advances Randomized Trials in Spinal and Ankle Fusion .
Clinical evidence generation for synthetic bone graft substitutes continues to expand. Kuros Biosciences reported progress across 3 prospective trials evaluating its MagnetOs bone graft technology, with enrollment reaching 97% in PROOF, 55% in PRECISE and 18% in ASTRA. The studies investigate fusion applications in the spine and hindfoot or ankle. The company also reported 40% year-over-year medical device sales growth and expanded US manufacturing. These developments indicate growing clinical and commercial activity, although definitive comparative trial results are still pending.
Read the full News article from Ortho Spine News
Read Article
AVISO LEGAL
O conteúdo desta página destina-se apenas a fins informativos e não pretende substituir o aconselhamento, diagnóstico ou tratamento médico profissional. Se necessitar de tratamento médico, procure sempre o conselho do seu médico ou dirija-se ao serviço de urgência mais próximo. As opiniões, crenças e pontos de vista expressos pelos indivíduos no conteúdo encontrado nesta página não reflectem as opiniões, crenças e pontos de vista da OrthoEvidence.
